Phase Ib study of dabrafenib, trametinib, irinotecan and cetuximab in BRAF V600E-mutated metastatic colorectal cancer.

Authors

null

Yungchang Chen

Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China;

Yungchang Chen , Xiaoqian Li , Man Yuxin , Hai Hu , Liyang Wang , Zhixuan Zhang , Ping Chen , Yang Liu , Jin Lu , Tongyu Lin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

ChiCTR2200063316

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 156)

DOI

10.1200/JCO.2023.41.4_suppl.156

Abstract #

156

Poster Bd #

H15

Abstract Disclosures